Condition
Cannabis Use Disorder, Moderate
Total Trials
7
Recruiting
2
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
7Total
Not Applicable (4)
Early P 1 (1)
P 2 (2)
Trial Status
Completed3
Recruiting2
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04567394Not ApplicableActive Not Recruiting
Cannabis Use Disorder Treatment Study
NCT04964739Not ApplicableCompleted
Gender/Sex & CUD Remission
NCT05064319Phase 2Recruiting
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
NCT06225232Phase 2RecruitingPrimary
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
NCT04902092Not ApplicableCompletedPrimary
Brain Exercise and Addiction Trial
NCT04923230Not ApplicableCompleted
Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse
NCT04106336Early Phase 1UnknownPrimary
Cortical Excitability and Role of rTMS in Cannabis Use Disorder
Showing all 7 trials